Esperion Therapeutics Shares Are Trading Higher After the Company Announced That Its European Partner, Daiichi Sankyo Europe, Reported Final 2-year Follow-up Data From the German Cohort of the Multinational, European Observational MILOS Study.
Esperion Therapeutics Shares Are Trading Higher After the Company Announced That Its European Partner, Daiichi Sankyo Europe, Reported Final 2-year Follow-up Data From the German Cohort of the Multinational, European Observational MILOS Study.
esperion therapeutics股價上漲，因爲該公司宣佈其歐洲合作伙伴戴興三共歐洲公司發佈了來自德國隊的跨國歐洲MILOS研究的最終2年隨訪數據。
Esperion Therapeutics Shares Are Trading Higher After the Company Announced That Its European Partner, Daiichi Sankyo Europe, Reported Final 2-year Follow-up Data From the German Cohort of the Multinational, European Observational MILOS Study.
esperion therapeutics股價上漲，因爲該公司宣佈其歐洲合作伙伴戴興三共歐洲公司發佈了來自德國隊的跨國歐洲MILOS研究的最終2年隨訪數據。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間